期刊文献+

ICU产ESBLs大肠埃希菌与肺炎克雷伯菌感染的分布及耐药性分析 被引量:11

Distribution and drug resistance of ICU producing Escherichia coli and Klebsiella pneumoniae infection
原文传递
导出
摘要 目的了解本地区ICU分离的产ESBLs大肠埃希菌和肺炎克雷伯菌的分布及对常用抗菌药物的耐药性,为临床抗菌药物的合理使用提供依据。方法采用K-B纸片扩散法,检测2013年-2015年ICU感染类标本分离的无重复的778株大肠埃希菌和570株肺炎克雷伯菌的耐药情况,并对结果进行统计分析。结果 2013年-2015临床标本中产ESBLs大肠埃希菌和肺炎克雷伯菌的检出率分别为52.96%和44.74%,ICU产ESBLs大肠埃希菌对美罗培南、亚胺培南、阿米卡星、哌拉西林/他唑巴坦、头孢哌酮/舒巴坦的耐药率为0.00%~30.34%。产ESBLs肺炎克雷伯菌对美罗培南、亚胺培南、阿米卡星、哌拉西林/他唑巴坦、头孢哌酮/舒巴坦的耐药率为0.00%~23.53%。ICU产ESBLs菌株耐药率明显高于非产ESBLs菌株,差异有统计学意义(P〈0.05)。结论 ICU产ESBLs大肠埃希菌与肺炎克雷伯菌对各类抗菌药物呈现不同程度耐药,并具多药耐药特点,碳青霉烯类仍是最敏感的药物;应加强产ESBLs菌株的监测及耐药性分析,以指导临床合理应用抗菌药物,对控制产ESBLs菌株的播散以及耐药基因的传播具有重要意义。 Objective To investigate the distribution and resistance of ICU isolated ESBLs producing Escherichia coli and Klebsiella pneumoniae to commonly used antibiotics, so as to provide the basis for the rational use of antimicrobial drugs.Methods K-B diffusion method was used to detect the drug resistance of 778 strains of Escherichia coli and 570 strains of Klebsiella pneumoniae isolated from ICU infected samples from 2013 to 2015,and the results were statistically analyzed.Results During 2013-2015 detection rate of ESBLs in clinical specimens of Klebsiella pneumoniae and Escherichia coli were52. 96% and 44. 74%,ICU ESBLs producing Escherichia coli to meropenem,imipenem,A Mika star,piperacillin / tazobactam,cefoperazone / sulbactam was within 0. 00%-30. 34%. That of ESBLs-producing Klebsiella pneumoniae to meropenem,imipenem,amikacin,piperacillin / tazobactam,cefoperazone / sulbactam was within 0. 00%-23. 53%. The resistance rate of ICU producing ESBLs strains was significantly higher than that of non-ESBLs-producing strains,the difference was statistically significant( P〈0. 05). Conclusion ICU ESBLs-producing Escherichia coli and Klebsiella pneumoniae for all types of antibiotics showed varying degrees of resistance and multidrug resistance characteristics,carbapenem is still the most sensitive drug;ESBLs-producing strains should be conducted to strengthen monitoring and analysis of drug resistance to guide clinical rational use of antimicrobial drugs,which is vital for controlling the spread of resistance genes and ESBLs strains.
出处 《中国卫生检验杂志》 CAS 2016年第11期1658-1660,共3页 Chinese Journal of Health Laboratory Technology
关键词 ICU 超广谱Β-内酰胺酶 大肠埃希菌 肺炎克雷伯菌 耐药性 ICU Extended-spectrum β-spectrum lactamases Escherichia coli Klebsiella pneumoniae Drug resistance
  • 相关文献

参考文献9

二级参考文献53

  • 1张剑,杜英姿,王能一,刘永杰,胡志东.ESBLs的研究进展[J].医学检验与临床,2008,20(2):80-82. 被引量:17
  • 2张才仕,杨莲,刘平.大肠埃希菌产超广谱β-内酰胺酶耐药监测[J].中华医院感染学杂志,2007,17(3):340-341. 被引量:18
  • 3张秋桂.产ESBLs大肠埃希菌和肺炎克雷伯菌耐药分析[J].中华医院感染学杂志,2007,17(4):457-458. 被引量:62
  • 4王贺,徐英春,陈民钧.细菌质粒介导的喹诺酮类抗菌药物耐药机制研究进展[J].中华医院感染学杂志,2007,17(5):618-620. 被引量:151
  • 5Demirdaq K, Hosoqlu S. Epidemiology and risk factors for ESBL-produ- cing Klebsiella pneumoniae : a case control study [ J ]. J Infect Dev Ctries,2010,4( 11 ) :717-722.
  • 6Yang YS, Ku CH, Lin JC, hang ST, et al. Impact of Extended-spectrum β-lactamase-producing Escherichla coli and Klebsiella pneumoniae on the Outcome of Community-onset Bacteremic Urinary Tract Infections [ J ]. J Microbiol immunol infect,2010,43 ( 3 ) : 194-197.
  • 7Wei ZQ,Du XX,Yu YS,et al. Plasmid-mediated KPC-2 in a Klebsiel- la pneumoniae isolate from China[ J]. Antimicrob Agents Chemother, 2007,51 (2) :763-765.
  • 8zClinical and Laboratory Standards Institute. M100-S20 Per- formance standards for antimicrobial susceptibility testing twentieth informational supplement[S]. CLSI,2010.
  • 9Vinue L, Saenz Y, Somalo S, et al. Prevalence and diversity of integrons and associated resistance genes in faecal Escherichia coli isolates of healthy humans in Spainl[J]. J Antimierob Chemother,2008,62(5) :934-937.
  • 10National Committee for Clinical Laboratory Standards. Per- formance standards for antimicrobial susceptibility testing [S]. Waryne Pennsylvania: NCCLS, 2009.

共引文献111

同被引文献107

引证文献11

二级引证文献72

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部